Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Proniras

Request full access

Developing therapies to help those fighting addiction

Seattle, United StatesFounded 2016Biotech & Life Sciences

About Proniras

Proniras Corporation is a preclinical stage biotechnology company dedicated to the development of Tezampanel, a parenteral medical countermeasure (MCM) aimed at treating seizures and brain injuries caused by exposure to organophosphorus nerve agents. The company operates within the life sciences sector, focusing primarily on medical countermeasures for neurological conditions. Proniras serves governmental and defense agencies, as well as healthcare providers who require advanced treatments for nerve agent-induced conditions.

The business model revolves around research and development (R&D) funded through government contracts and grants. Proniras recently secured a significant contract worth up to $89.5 million from the U.S. Biomedical Advanced Research and Development Authority (BARDA) to further develop Tezampanel. This funding supports their preclinical trials and eventual commercialization of the drug.

Revenue is generated through these government contracts and potential future sales of Tezampanel upon successful development and approval. The company aims to address a critical gap in medical countermeasures for nerve agent-induced seizures, positioning itself as a key player in this niche market.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
Seattle, United States
Sector
Biotech & Life Sciences

Proniras in the Seattle ecosystem

Live from Dealroom

The Proniras office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Accelerator Life Science Partners

Series A3 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Proniras on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Proniras on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.